ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 8.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,575 | -3.4% | 450,535 | -2.4% | 0.00% | – |
| Q2 2023 | $937,075 | +0.8% | 461,613 | -1.2% | 0.00% | – |
| Q1 2023 | $929,738 | -14.6% | 467,205 | +1.7% | 0.00% | – |
| Q4 2022 | $1,088,790 | +15.1% | 459,405 | +0.1% | 0.00% | – |
| Q3 2022 | $946,000 | -17.5% | 459,170 | -0.2% | 0.00% | – |
| Q2 2022 | $1,146,000 | +8.4% | 460,218 | +0.1% | 0.00% | – |
| Q1 2022 | $1,057,000 | +20.9% | 459,562 | +13.1% | 0.00% | – |
| Q4 2021 | $874,000 | -29.2% | 406,283 | -2.6% | 0.00% | – |
| Q3 2021 | $1,235,000 | -11.2% | 417,258 | +4.7% | 0.00% | – |
| Q2 2021 | $1,391,000 | +177.1% | 398,507 | +189.8% | 0.00% | – |
| Q1 2021 | $502,000 | +43.0% | 137,498 | +56.9% | 0.00% | – |
| Q4 2020 | $351,000 | +466.1% | 87,619 | +527.1% | 0.00% | – |
| Q3 2020 | $62,000 | – | 13,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 706,930 | $1,406,791 | 1.22% |
| Newtyn Management, LLC | 519,765 | $1,034,332 | 0.20% |
| Murchinson Ltd. | 52,800 | $100,680 | 0.01% |
| Marquette Asset Management, LLC | 17,318 | $34,463 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $93,427 | 0.00% |
| Tekla Capital Management LLC | 32,461 | $64,597 | 0.00% |
| OSAIC HOLDINGS, INC. | 57 | $113 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 42,502 | $84,579 | 0.00% |
| Parallel Advisors, LLC | 244 | $486 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 31 | $62 | 0.00% |